Parnalia Equities

Long-only public equities. Fundamental research + disciplined portfolio construction. Publicly tracked strategy since 2023. Research, positions & lessons.

[Parnalia Equities @ParnaliaEquity]

@CapexAndChill Hopefully it doesn’t keep getting attractive perpetually.

[Parnalia Equities @ParnaliaEquity]

Strategy faces a risk beyond Bitcoin’s price.

MSCI’s revised index methodology could remove $MSTR from major equity benchmarks, potentially triggering selling by index-tracking funds.

The implications extend to institutional ownership, liquidity and market valuation.

Exclusion remains unconfirmed.

[Parnalia Equities @ParnaliaEquity]

Reuters reports Sea is planning a public listing of Monee, its digital financial services arm.

For $SE, the strategic question extends beyond valuation: can an independently listed fintech accelerate expansion while preserving Shopee’s distribution advantages?

IPO timing, structure and terms remain unconfirmed.

[Parnalia Equities @ParnaliaEquity]

ASML expects its planned lithography-system supply in 2027–28 to fall short of customer demand.

It is evaluating further capacity expansion, while some customers have expressed interest in orders extending into 2029–30.

For $ASML, the critical variable is increasingly manufacturing execution—not simply AI-driven demand.

[Parnalia Equities @ParnaliaEquity]

Novo Nordisk’s latest CagriSema analysis adds evidence of substantial weight-loss efficacy in women across menopausal stages.

The distinction is methodological: these are exploratory, retrospective subgroup findings—not proof that treatment response differs by menopausal stage.

For $NVO , the focus remains on regulatory approval, tolerability and commercial differentiation.

[Parnalia Equities @ParnaliaEquity]

IonQ’s latest financing strengthens its capacity to scale quantum technology, but access to capital is not commercial validation.

For $IONQ , the next test is translating technical progress into sustained customer adoption, repeatable revenue and disciplined capital deployment.

The long-term investment case increasingly depends on execution, not funding availability.

[Parnalia Equities @ParnaliaEquity]

Visa, BILL and Billtrust have launched a live pilot enabling AI agents to complete buyer-approved invoice payments through supplier portals.

The important distinction: AI executes the payment; it does not make the spending decision.

For $V , the strategic opportunity is broader B2B card acceptance by removing manual payment friction.

The pilot is live and processing transactions. Commercial scale remains unproven.

[Parnalia Equities @ParnaliaEquity]

$ASML's Q3 update signaled more than a record quarter: customers are discussing orders for 2029–30, while ASML says planned 2027–28 supply may not fully meet demand.

AI capex visibility is stretching unusually far out.

[Parnalia Equities @ParnaliaEquity]

Strategy’s ($MSTR ) Oct. 19 filing is more interesting for capital allocation than the BTC headline:

$193.1M spent repurchasing STRC versus $22.1M on 267 BTC.

Preferred-equity support absorbed far more capital than Bitcoin accumulation this week.

[Parnalia Equities @ParnaliaEquity]

$IONQ raised $2.0B and says the capital will accelerate commercialization across computing, networking, sensing, and security.

[Parnalia Equities @ParnaliaEquity]

📈 Long Horizon vs $SPY | 2026-10-15

Performance Snapshot
⚡ Annualized Return: 40.8%
💰 Live Capital: $190k

🔥 Today's P/L leaders: $MRNA $AFRM $MU

👉 Copy this portfolio
C2: https://t.co/kePfXJR6Ff
Savvy: https://t.co/IRZYURxaqM

[Parnalia Equities @ParnaliaEquity]

@kevinxu overbought

[Parnalia Equities @ParnaliaEquity]

@Long03131983 Still bullish on $ACHR, just not holding through this weakness.

[Parnalia Equities @ParnaliaEquity]

Oct 14, 2026: $ACHR (Archer Aviation Inc)

Sold 843 shares (100.00% of position) at $4.22 for a 33.22% loss.

https://t.co/y2vmPfMiAn

[Parnalia Equities @ParnaliaEquity]

$UBER’s ezCater deal looks less like another delivery acquisition and more like a move up the order-value curve.

Workplace meals and catering bring recurring enterprise demand into the Uber Eats + Uber for Business ecosystem—where large-group orders behave very differently from typical consumer deliveries.

The interesting question is whether Uber can turn that B2B demand into a higher-value layer on top of its existing logistics network.

Disclosure: Parnalia Equities holds $UBER.

[Parnalia Equities @ParnaliaEquity]

The important part of AstraZeneca’s $2B investment in $SMMT may be what came with the check.

Ivonescimab is now being positioned alongside AstraZeneca’s ADC portfolio across multiple tumor types — including planned combinations beyond a single asset or indication.

That turns the relationship into more than financing: it creates a potentially broad clinical-development platform around PD-1/VEGF + ADC combinations.

Disclosure: Parnalia Equities holds SMMT.

[Parnalia Equities @ParnaliaEquity]

$IONQ’s Elisity deal is more interesting than “quantum company buys cybersecurity firm.”

Elisity gives IonQ an installed enterprise security channel with 100+ deployments — a distribution layer for PQC, QKD, and eventually broader quantum products.

The strategic question is shifting from “how good is the quantum hardware?” toward “how much of the enterprise stack can IonQ own?”

Disclosure: Parnalia holds $IONQ.

[Parnalia Equities @ParnaliaEquity]

IonQ’s Elisity deal is really a distribution bet.

Elisity brings 100+ enterprise deployments; IonQ brings PQC and quantum-secure networking.

The question: can today’s Zero Trust spend become the commercialization bridge to tomorrow’s quantum security?

Disclosure: Parnalia Equities holds $IONQ.

[Parnalia Equities @ParnaliaEquity]

📈 Long Horizon vs $SPY | 2026-10-09

Performance Snapshot
⚡ Annualized Return: 41.6%
💰 Live Capital: $194k

🔥 Today's P/L leaders: $MRNA $PBR $RBRK

👉 Copy this portfolio
C2: https://t.co/kePfXJR6Ff
Savvy: https://t.co/IRZYURxaqM

[Parnalia Equities @ParnaliaEquity]

@Divergent7651 Great analysis! We opened a position today. $RELX